Hyperglycemia Post-Influenza Vaccine in Patients With Diabetes.

Abigail L HulsizerAmy P WitteRebecca L AttridgeElizabeth M Urteaga

Published in: The Annals of pharmacotherapy (2022)

Hyperglycemia was noted 0 to 24 hours post-vaccination and was transient in nature with a return to baseline by post-vaccination day 2. This trial was conducted to close a potential gap in counseling regarding the flu vaccine and decrease any potential concern surrounding the vaccine in patients with diabetes that could lead to reduced vaccination rates.

Keyphrases

study protocol
human health
randomized controlled trial
risk assessment
smoking cessation
oxidative stress
climate change
hepatitis c virus
blood brain barrier
open label
brain injury
hiv testing